Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Antonio Mastrolorenzo"'
Autor:
Margherita Vannucchi, Antonietta D’Errico, Stefano Giannini, Fiammetta Fossi, Antonio Mastrolorenzo, Piera Pierotti
Publikováno v:
World Journal of Dermatology. 6:59-65
Publikováno v:
Università degli studi di Firenze-IRIS
The objective of this study was the development of a niosomal formulation for improving skin permeation and penetration of 5-aminolevulinic acid (ALA) in the treatment of skin malignancies by photodynamic therapy (PDT). Different niosomal dispersions
Autor:
Claudiu T. Supuran, Antonio Mastrolorenzo, Fritz A. Mühlschlegel, Worraanong Leewattanapasuk, Daniela Vullo, Clemente Capasso
Publikováno v:
Bioorganic & Medicinal Chemistry Letters
The fungal pathogen Candida glabrata encodes for a β-carbonic anhydrase (CA, EC 4.2.1.1), CgNce103, recently discovered. Only anions have been investigated as CgNce103 inhibitors up until now. Here we report the first sulfonamides inhibition study o
Autor:
Barbara Giomi, Antonio Mastrolorenzo, L Tiradritti, Nicola Decarli, Elisa Margherita Difonzo, Emanuele Maria Cipollini, Rosario Tammaro, Francesca Fabiani Tropeano, Daniele Cammelli, Giuliano Zuccati
Publikováno v:
International Journal of Dermatology. 51:1082-1085
Background Mycetoma is generally understood to be a chronic suppurative infection involving the skin and the underlying tissue. Mycetomas may be classified as those produced by true fungi (eumycetoma) versus those due to aerobic bacteria Actinomyceta
Publikováno v:
Current Enzyme Inhibition. 7:2-23
Autor:
Antonio Mastrolorenzo, Andrea Scozzafava, Fritz A. Mühlschlegel, Rebecca A. Hall, Alfonso Maresca, Claudiu T. Supuran, Özlen Güzel
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 20:2508-2511
A series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides and 1-({[5-(aminosulfonyl)-3-phenyl-1H-indol-2-yl]carbonyl}amino)-2,4,6 trimethylpyridinium perchlorates possessing various 2-, 3- or 4-substituted phenyl groups with met
Publikováno v:
Future HIV Therapy. 2:479-507
HIV fusion and entry are two steps in the viral lifecycle that can be targeted by several classes of antiviral drugs. The discovery of chemokines focused the attention on cellular co-receptors used by the virus for entering cells, and on the various
Autor:
Giuseppe Barbaro, Antonio Mastrolorenzo, Claudiu T. Supuran, Andrea Scozzafava, Stefano Rusconi
Publikováno v:
Current Medicinal Chemistry. 14:2734-2748
The introduction of highly active antiretroviral therapy (HAART) in 1996 dramatically changed the course of HIV infection. This therapy involves the use of at least three agents from two distinct classes of antivirals: a protease inhibitor (PI) in co
Autor:
Antonio Mastrolorenzo, Alessio Innocenti, Claudiu T. Supuran, Claudia Temperini, Andrea Scozzafava
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:4866-4872
Sulthiame, a clinically used antiepileptic, was investigated for its interaction with 12 catalytically active mammalian carbonic anhydrase (CA, EC 4.2.1.1) isoforms. The drug is a potent inhibitor of CA II, VII, IX, and XII ( K I s of 6–56 nM), and
Autor:
Claudiu T. Supuran, Claudia Temperini, Andrea Scozzafava, Antonio Mastrolorenzo, Alessio Innocenti
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 17:628-635
The activation of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1) with l -adrenaline and histamine has been investigated by kinetic and X-ray crystallographic studies. l -Adrenaline behaves as a potent activator of isozyme CA I (activation cons